JPS5095285A - - Google Patents
Info
- Publication number
- JPS5095285A JPS5095285A JP14394773A JP14394773A JPS5095285A JP S5095285 A JPS5095285 A JP S5095285A JP 14394773 A JP14394773 A JP 14394773A JP 14394773 A JP14394773 A JP 14394773A JP S5095285 A JPS5095285 A JP S5095285A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14394773A JPS5095285A (es) | 1973-12-26 | 1973-12-26 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14394773A JPS5095285A (es) | 1973-12-26 | 1973-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5095285A true JPS5095285A (es) | 1975-07-29 |
Family
ID=15350740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14394773A Pending JPS5095285A (es) | 1973-12-26 | 1973-12-26 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5095285A (es) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995018097A1 (fr) * | 1993-12-27 | 1995-07-06 | Eisai Co., Ltd. | Derive de l'acide anthranilique |
| JP2006513154A (ja) * | 2002-10-21 | 2006-04-20 | ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド | カリウムチャネルおよび／または皮質ニューロン活性モジュレーターとしての、ｎ−フェニルアントラニル酸および２−ベンズイミダゾロンの誘導体 |
| US8278357B2 (en) | 2002-10-21 | 2012-10-02 | Ramot At Tel-Aviv University Ltd. | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| WO2012131656A3 (en) * | 2011-04-01 | 2012-11-22 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| US8765815B2 (en) | 2007-09-20 | 2014-07-01 | Ramot At Tel-Aviv University Ltd. | N-phenyl anthranilic acid derivatives and uses thereof |
| US9233931B2 (en) | 2008-01-10 | 2016-01-12 | Centre Nationale De Recherche Scientifique | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| JP2016530317A (ja) * | 2013-09-11 | 2016-09-29 | ジ・アドミニストレーターズ・オブ・ザ・チューレーン・エデュケーショナル・ファンド | 新規アントラニルアミドとその使用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4840789A (es) * | 1971-10-07 | 1973-06-15 |
-
1973
- 1973-12-26 JP JP14394773A patent/JPS5095285A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4840789A (es) * | 1971-10-07 | 1973-06-15 |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995018097A1 (fr) * | 1993-12-27 | 1995-07-06 | Eisai Co., Ltd. | Derive de l'acide anthranilique |
| JP2006513154A (ja) * | 2002-10-21 | 2006-04-20 | ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド | カリウムチャネルおよび／または皮質ニューロン活性モジュレーターとしての、ｎ−フェニルアントラニル酸および２−ベンズイミダゾロンの誘導体 |
| US8278357B2 (en) | 2002-10-21 | 2012-10-02 | Ramot At Tel-Aviv University Ltd. | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| US8618169B2 (en) | 2002-10-21 | 2013-12-31 | Ramot At Tel-Aviv University Ltd. | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| US8765815B2 (en) | 2007-09-20 | 2014-07-01 | Ramot At Tel-Aviv University Ltd. | N-phenyl anthranilic acid derivatives and uses thereof |
| US9403756B2 (en) | 2007-09-20 | 2016-08-02 | Ramot At Tel-Aviv University Ltd. | N-phenyl anthranilic acid derivatives and uses thereof |
| US10130595B2 (en) | 2008-01-10 | 2018-11-20 | Centre Nationale De Recherche Scientifique | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| US9233931B2 (en) | 2008-01-10 | 2016-01-12 | Centre Nationale De Recherche Scientifique | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| US10654813B2 (en) | 2008-01-10 | 2020-05-19 | Centre National De La Recherche Scientifique | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| WO2012131656A3 (en) * | 2011-04-01 | 2012-11-22 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| US9890112B2 (en) | 2011-04-01 | 2018-02-13 | Abivax | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| US10538485B2 (en) | 2011-04-01 | 2020-01-21 | Abivax | Compounds for use as therapeutic agents affecting P53 expression and/or activity |
| JP2016530317A (ja) * | 2013-09-11 | 2016-09-29 | ジ・アドミニストレーターズ・オブ・ザ・チューレーン・エデュケーショナル・ファンド | 新規アントラニルアミドとその使用 |
| US11465978B2 (en) | 2013-09-11 | 2022-10-11 | The Administrators Of The Tulane Educational Fund | Anthranilic amides and the use thereof |